During the past decade, Alzheimer's Research Corporation conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alzheimer's Research Corporation" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials, followed by "Epix Pharmaceuticals, Inc." with 2 trials sponsored, "Cerecin" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Mediti Pharma Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alzheimer's Research Corporation" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Neuro-Hitech" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Alzheimer's Research Corporation" are "Alzheimer's Disease" (9 trials), "Alzheimer Disease" (2 trials), "Aggression" (1 trials), "Agitation" (1 trials) and "Alzheimer Dementia" (1 trials). Many other conditions were trialed in "Alzheimer's Research Corporation" in a lesser frequency.

Most popular intervention types in "Alzheimer's Research Corporation" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "PRX-03140" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alzheimer's Research Corporation" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Alzheimer's Research Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Alzheimer's Research Corporation, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Alzheimer's Research Corporation, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".